Emerging Nanotechnology for the Treatment of Alzheimer's Disease.

Singh, Aditya; Ansari, Vaseem Ahamad; Mahmood, Tarique; Ahsan, Farogh; Wasim, Rufaida; Maheshwari, Shubhrat; Shariq, Mohammad; Parveen, Saba; Shamim, Arshiya

Singh, Aditya; Ansari, Vaseem Ahamad; Mahmood, Tarique; Ahsan, Farogh; Wasim, Rufaida; Maheshwari, Shubhrat; Shariq, Mohammad; Parveen, Saba; Shamim, Arshiya.

Afiliación

Singh A; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Ansari VA; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Mahmood T; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Ahsan F; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Wasim R; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Maheshwari S; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Shariq M; Faculty of Pharmaceutical Sciences Rama University Mandhana, Bithoor Road, Kanpur, Uttar Pradesh-209217(India).
Parveen S; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).
Shamim A; Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, UP-226026 (India).

CNS Neurol Disord Drug Targets ; 2023 May 01.

Article en En | MEDLINE | ID: mdl-37138478

Palabras clave

Alzheimer's disease; Nanoparticle.; Nanotechnology; Neurodegenerative; Ursolic acid; bioavailability

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: CNS Neurol Disord Drug Targets Asunto de la revista: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google